BiotaX Labs News
2 articles
growth-positive
An Israeli development will replace one of the most intrusive and frightening examinations with a simple at-home test
The article discusses a new attack on machine learning where an adversary poisons a training set to harm the privacy of other users data. It also mentions that c3 Communications has started its 23rd year in business with 5 new clients. The impact on the company is growth-positive. The key theme of the article is the privacy implications of the new attack on machine learning. The key issue discussed is the potential harm to the privacy of users data. The article does not mention any specific partners, customers, valuation amount, acquisition amount, investment amount, layoffs, or date of the event. The confidence level is 7 out of 10.
Customers
growth-positive
Press Release
Illumina, Inc. has selected nine new genomics companies to join the second global funding cycle of Illumina Accelerator. The company has also secured over £20 million in initial UK capital commitments, including a £10 million commitment from cornerstone investor LifeArc. The capital commitments will provide match funding to every Illumina Accelerator Cambridge graduate that secures between £500,000 up to £4 million in qualified new capital. Illumina Accelerator provides selected startups with seed investment, access to Illumina sequencing systems and reagents, business guidance, genomics expertise, and lab space. The newest companies to join Illumina Accelerators portfolio include BiotaX Labs, Broken String Biosciences, Mitra Bio, MultiplAI Health, Doloromics Inc., Flightpath Biosciences, Oshun Medical, Parallel Health, and Rubik Therapeutics. Illumina Accelerator is accepting applications for the next funding cycle.
InvestmentExpand
